ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "morbidity and mortality"

  • Abstract Number: L04 • 2019 ACR/ARP Annual Meeting

    Cardiovascular Disease Risk in Calcium Pyrophosphate Deposition Disease

    Maaman Bashir1, Katherine Sherman 2, Sara K. Tedeschi 3 and Ann Rosenthal 1, 1Medical College of Wisconsin, Milwaukee, 2Milwaukee VAMC, Milwaukee, 3Brigham and Women's Hospital, Div. of Rheumatology, Immunology and Allergy, Boston

    Background/Purpose: Calcium pyrophosphate deposition (CPPD) disease results from precipitation of calcium pyrophosphate (CPP) crystals in joints. Prior studies demonstrated that vascular calcification is more common…
  • Abstract Number: 955 • 2019 ACR/ARP Annual Meeting

    Adherence to Statin Therapy in Rheumatoid Arthritis Patients: A Population-Based Cohort Study

    Tom Hahn 1, Eric Sayre 2, Maria Victoria Goycochea-Robles 3 and Diane Lacaille4, 1Department of Medicine, University of British Columbia, Vancouver, Canada, 2Arthritis Research Canada, Vancouver, BC, Canada, 3Unidad de Investigación en Epidemiologia HGR 1, Mexican Institute of Social Security -, Mexico City, Mexico, 4Arthritis Research Canada and University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Cardiovascular diseases (CVD) are increased in RA and lead to premature mortality. Statins are effective at preventing incidence of, and mortality from, CVD; yet,…
  • Abstract Number: 1219 • 2019 ACR/ARP Annual Meeting

    Uric Acid Level as a Predictor of Long Term Mortality in Advanced Age Population

    ‪Gabriel Breuer‬‏1, Marwan Abu Sneineh‬‏ 1 and Gideon Nesher 1, 1Shaare Zedek Medical Center, Jerusalem, Yerushalayim, Israel

    Background/Purpose: Hyperuricemia is associated with the development, progression and outcome of several diseases. The purpose of this study is to evaluate the serum uric acid…
  • Abstract Number: 1562 • 2019 ACR/ARP Annual Meeting

    The Association of Body Weight Fluctuation and All-Cause Mortality in Patients with Systemic Lupus Erythematosus

    Sarah Bayefsky1, Alyson Dickson 1, Tyler Reese 1, Jocelyn Gandelman 2, Megan Shuey 1, April Barnado 1, Katherine Barker 1, C. Michael Stein 1, Vivian Kawai 1 and Cecilia Chung 1, 1Vanderbilt University Medical Center, Nashville, TN, 2Vanderbilt University School of Medicine, Nashville, TN

    Background/Purpose: Recent studies have suggested that body weight fluctuation in the general population is an independent risk factor for overall mortality. These findings are of…
  • Abstract Number: 1718 • 2019 ACR/ARP Annual Meeting

    Geographic Disparities in Mortality Rates of Vasculitis in the United States: 1999 to 2017

    Alicia Rodriguez-Pla1, 1University of Arizona/Banner Health Medical Center, Tucson, AZ

    Background/Purpose: Earlier diagnosis and less toxic immunosuppressive therapies have improved the survival of patients with vasculitis. Current data on mortality rates of vasculitis are limited.…
  • Abstract Number: 2136 • 2019 ACR/ARP Annual Meeting

    Cardiovascular Risk Evaluation in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Results from the “Cardiovascular Obesity and Rheumatic DISease (CORDIS)” Study Group of the Italian Society of Rheumatology

    Fabio Cacciapaglia1, Gian Luca Erre 2, Garifallia Sakellariou 3, Ombretta Viapiana 4, Matteo Piga 5, Elena Bartoloni 6, Andreina Manfredi 7, Sergio Colella 1, Floriana Castagna 2, Giacomo Cafaro 8, Martina Dessì 5, Marco Fornaro 1, Alessandro Giollo 9, Silvia Grignaschi 10, Caterina Vacchi 11, Francesca Romana Spinelli 12, Fabiola Atzeni 13 and Elisa Gremese 14, 1Rheumatology Unit – Department of Emergency and Organs Transplantation, University and AOU Policlinico of Bari, Italy, Bari, Italy, 2Specialità Mediche, Azienda Ospedaliero Universitaria di Sassari, Italy., Sassari, Italy, 3Division of Rheumatology, University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy, 4University of Verona, Verona, Italy, 5Rheumatology Unit, Department of Medical Sciences, University and AOU Policlinico of Cagliari, Italy., Cagliari, Italy, 6Rheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy, Perugia, Italy, 7Rheumatology Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Emilia-Romagna, Italy, 8Rheumatology Unit, Department of Medicine, University of Perugia, Italy., Perugia, Italy, 9Rheumatology Unit, Department of Medicine, University of Verona, Italy., Verona, Italy, 10Division of Rheumatology, University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy., Pavia, Italy, 11Rheumatology Unit, Department of Medical and Surgical Science, University and AOU Policlinico of Modena, Italy., Modena, 12Rheumatology, Department of Internal Medicine and Medical Speciality, Sapienza University of Rome, Italy., Rome, Italy, 13Rheumatology Unit, University of Messina, Messina, Italy., Messina, Italy, 14Fondazione Policlinico Gemelli-Università Cattolica del Sacro Cuore, Rome, Italy

    Background/Purpose: Systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients present high cardiovascular (CV) morbidity and mortality. International guidelines suggest estimating CV-risk in these patients,…
  • Abstract Number: 2605 • 2019 ACR/ARP Annual Meeting

    Men and Black Persons Die at Younger Ages from Systemic Sclerosis: A Nationwide Population-based Study

    Ram Raj Singh1, Devanshu Singh 2 and Eric Yen 1, 1UCLA, Los Angeles, 2Johns Hopkins University, Baltimore, MD

    Background/Purpose: Systemic sclerosis (SSc) is more common in women than men, but men tend to have a faster disease progression than women. However, conflicting results…
  • Abstract Number: 2628 • 2019 ACR/ARP Annual Meeting

    Mortality Predictors in ANCA-associated Vasculitis: Experience of a Brazilian Monocentric Cohort of a Rheumatology Center

    Marilia Dagostin1, Sergio Nunes 2, Samuel Shinjo 3 and Rosa Pereira 4, 1University of Sao Paulo, São Paulo, Brazil, 2Univeristy Of Sao Paulo, São Paulo, 3Univeristy Of Sao Paulo, São Paulo, Brazil, 4Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Sao Paulo, Brazil

    Background/Purpose: Mortality of patients with ANCA-associated vasculitis (AAV) is higher than the general population. There are few papers in the literature regarding the factors associated…
  • Abstract Number: 2917 • 2019 ACR/ARP Annual Meeting

    Geographic Disparities in Systemic Sclerosis Mortality in the United States: 1999 to 2017

    Alicia Rodriguez-Pla1 and Robert W Simms 2, 1University of Arizona/Banner Health Medical Center, Tucson, AZ, 2Boston University, Boston, MA

    Background/Purpose: Population mortality studies in the United States have previously reported a progressive increase in the scleroderma (SSc) mortality rates from 1959 to 2002. Identification…
  • Abstract Number: 834 • 2018 ACR/ARHP Annual Meeting

    Clinical Characteristics of IgA Vasculitis in Children and Adults: A Retrospective Cohort Study

    Michel Villatoro-Villar1, Cynthia S. Crowson1,2, Kenneth J. Warrington3, Ashima Makol1, Steven R. Ytterberg3 and Matthew J. Koster1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic, Rochester, MN, 3Rheumatology, Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN

    Background/Purpose: Differences in both presentation and outcome based on age of diagnosis have been described in patients with IgA vasculitis (IgAV) but data are limited…
  • Abstract Number: 872 • 2018 ACR/ARHP Annual Meeting

    Is the Serum Uric Acid Therapeutic Target Protective of Chronic Kidney Disease, Cardiovascular Disease, and Mortality for Patients with Gout? a Longitudinal Study

    Douglas C.A. Taylor1, Dena Jaffe2, Moshe Hoshen3, Galit Shefer3, Asaf Bachrach3, Becca Feldman3, An-Chen Fu1 and Hyon K. Choi4, 1Ironwood Pharmaceuticals, Inc., Cambridge, MA, 2Kantar Health, Tel Aviv, Israel, 3Clalit Research Institute, Tel Aviv, Israel, 4Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA

    Background/Purpose: Many studies have found that serum uric acid (sUA) levels are associated with the incidence of chronic kidney disease (CKD), cardiovascular disease (CVD), and…
  • Abstract Number: 1171 • 2018 ACR/ARHP Annual Meeting

    Mortality Among Those with OA: Time-Varying Effects of Socioeconomic Measures

    Becki Cleveland1, Todd Schwartz2, Amanda Nelson3, Jordan B. Renner4, Joanne M. Jordan5 and Leigh F. Callahan5, 1University of North Carolina at Chapel Hill, Chapel Hill, NC, 2Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, 3UNC School of Medicine, Chapel Hill, NC, 4UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, 5Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose: Measures of socioeconomic status (SES) have been shown to be associated with increased OA and disability. However, it is unknown whether changes in SES…
  • Abstract Number: 2503 • 2018 ACR/ARHP Annual Meeting

    Impact of Tobacco Smoking on 1-Year Mortality Following Total Hip and Total Knee Arthroplasty Among Rheumatoid Arthritis Patients – a Danish Cohort Study Using Nationwide Health Care Registers

    René Cordtz1,2, Laerke Bech-Illum3, Daniel Prieto-Alhambra4, Pil Hoejgaard3,5, Kristian Zobbe3,6, Nina Imbæk3 and Lene Dreyer7, 1Center for Rheumatology and Spine Diseases, Gentofte-Rigshospitalet, Hellerup, Denmark, 2The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark, Copenhagen, Denmark, 3Center for Rheumatology and Spine Diseases - Gentofte, Rigshospitalet, Hellerup, Denmark, 4Internal Medicine and Primary Care, URFOA-IMIM, Parc de Salut Mar; Idiap Jordi Gol i Gurina-Institut Català de la Salut; Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK, Barcelona, Spain, 5The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark, Denmark, 6The Parker Institute, Bispebjerg and Frederiksberg Hospital, Capital Region of Denmark, Copenhagen, Denmark, 7Departments of Rheumatology and Clinical Medicine, Aalborg University Hospital and Aalborg University, 9000 Aalborg, Denmark

    Background/Purpose: Tobacco smoking and rheumatoid arthritis (RA) are independent risk factors for short-term complications following total hip and total knee arthroplasty (THA/TKA). We aimed to…
  • Abstract Number: 2674 • 2018 ACR/ARHP Annual Meeting

    Identifying Phenotype Clusters in Systemic Lupus Erythematosus By Damage Cluster

    Ga Young Ahn1, Jiyoung Lee2, Eunji Ha3, Kwangwoo Kim3, Hyoungyoung Kim1, Ji Soong Kim1, Bora Nam1, Juyeon Kang1, Hyuk-Hee Kwon1, So-Young Bang1, Hye-Soon Lee1 and Sang-Cheol Bae1, 1Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South), 2Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, Korea, Republic of (South), 3Biology, Kyung Hee University, Seoul, Korea, Republic of (South)

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a multisystem autoimmune disease with complex genetic background. Recently, subphenotype in SLE has influenced dialogue on discussing the genetic…
  • Abstract Number: 2803 • 2018 ACR/ARHP Annual Meeting

    48-Year Trends in Systemic Sclerosis Mortality in the United States, 1968-2015: Steady Decrease for 15 Years after 33 Years of Continuous Increase

    Eric Yen, Devanshu Singh and Ram R. Singh, UCLA, Los Angeles, CA

    Background/Purpose: A comprehensive evaluation of long-term trends in systemic sclerosis (SSc) mortality is important to understand the influence of recent advances in SSc management and…
  • 1
  • 2
  • 3
  • …
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology